Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1280

1.

Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.

Al-Allaf FA, Athar M, Abduljaleel Z, Taher MM, Khan W, Ba-Hammam FA, Abalkhail H, Alashwal A.

Gene. 2015 Jul 1;565(1):76-84. doi: 10.1016/j.gene.2015.03.064. Epub 2015 Apr 1.

PMID:
25839937
2.

Association of polymorphisms of genes involved in lipid metabolism with blood pressure and lipid values in mexican hypertensive individuals.

Ríos-González BE, Ibarra-Cortés B, Ramírez-López G, Sánchez-Corona J, Magaña-Torres MT.

Dis Markers. 2014;2014:150358. doi: 10.1155/2014/150358. Epub 2014 Dec 21.

3.

[Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia--what benefits do we gain compared with cholesterol measurements?].

Leiviskä J, Sundvall J, Jauhiainen M, Laatikainen T.

Duodecim. 2014;130(22-23):2331-7. Finnish.

PMID:
25558595
5.

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.

Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG.

Am Heart J. 2014 Nov;168(5):682-9. doi: 10.1016/j.ahj.2014.07.028. Epub 2014 Aug 7.

6.

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB.

Sniderman AD, Lamarche B, Contois JH, de Graaf J.

Curr Opin Lipidol. 2014 Dec;25(6):461-7. doi: 10.1097/MOL.0000000000000127. Review.

PMID:
25340478
7.

Therapeutic lipid target achievements among high and highest risk patients: results from the CEPHEUS study in the Arabian Gulf.

Al-Rasadi K, Al-Zakwani I, Al Mahmeed W, Arafah M, Al-Hinai AT, Shehab A, Al Tamimi O, Alawadhi M.

Curr Med Res Opin. 2014 Dec;30(12):2429-35. doi: 10.1185/03007995.2014.965774. Epub 2014 Sep 29.

PMID:
25222765
8.

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2465-72. doi: 10.1161/ATVBAHA.114.303932. Epub 2014 Sep 11.

PMID:
25212234
9.
10.

Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

d'Emden MC, Jenkins AJ, Li L, Zannino D, Mann KP, Best JD, Stuckey BG, Park K, Saltevo J, Keech AC; FIELD Study Investigators.

Diabetologia. 2014 Nov;57(11):2296-303. doi: 10.1007/s00125-014-3344-3. Epub 2014 Aug 23.

PMID:
25149070
11.

Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides.

Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP.

Atherosclerosis. 2014 Oct;236(2):244-50. doi: 10.1016/j.atherosclerosis.2014.07.008. Epub 2014 Jul 22.

PMID:
25105581
12.

Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.

Gianfagna F, Veronesi G, Guasti L, Chambless LE, Brambilla P, Corrao G, Mancia G, Cesana G, Ferrario MM.

Atherosclerosis. 2014 Sep;236(1):175-81. doi: 10.1016/j.atherosclerosis.2014.06.029. Epub 2014 Jul 14.

PMID:
25062081
13.

Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury.

Lei X, Basu D, Li Z, Zhang M, Rudic RD, Jiang XC, Jin W.

Atherosclerosis. 2014 Sep;236(1):121-30. doi: 10.1016/j.atherosclerosis.2014.06.015. Epub 2014 Jul 1.

PMID:
25026302
14.

Serum lipids, apolipoproteins, and mortality among coronary artery disease patients.

Ding D, Li X, Qiu J, Li R, Zhang Y, Su D, Li Z, Wang M, Lv X, Wang D, Yang Y, Xia M, Li D, Hu G, Ling W.

Biomed Res Int. 2014;2014:709756. doi: 10.1155/2014/709756. Epub 2014 May 29.

15.

The apolipoprotein B/apolipoprotein A-I ratio in healthy men with normolipidemia: limits of variation and relationship with other lipid parameters.

Kaneva AM, Potolitsyna NN, Bojko ER.

Clin Chem Lab Med. 2014 Dec;52(12):e291-3. doi: 10.1515/cclm-2014-0355. No abstract available.

PMID:
24940716
16.

The role of exercise training on lipoprotein profiles in adolescent males.

Koozehchian MS, Nazem F, Kreider RB, Roberts WJ, Best TM, Rong Y, Zuo L.

Lipids Health Dis. 2014 Jun 9;13:95. doi: 10.1186/1476-511X-13-95.

17.

Subclinical atherosclerosis determinants in morbid obesity.

Megias-Rangil I, Merino J, Ferré R, Plana N, Heras M, Cabré A, Bonada A, Rabassa A, Masana L.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):963-8. doi: 10.1016/j.numecd.2014.04.012. Epub 2014 May 6.

PMID:
24907020
18.

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.

Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB.

Vasc Health Risk Manag. 2014 May 7;10:279-90. doi: 10.2147/VHRM.S58694. eCollection 2014.

19.

Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Corsetti JP, Gansevoort RT, Bakker SJ, Sparks CE, Vart P, Dullaart RP.

J Am Soc Nephrol. 2014 Dec;25(12):2906-15. doi: 10.1681/ASN.2013121256. Epub 2014 May 22.

PMID:
24854276
20.

Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension.

Baszczuk A, Musialik K, Kopczyński J, Thielemann A, Kopczyński Z, Kęsy L, Dopierała G.

Adv Med Sci. 2014 Mar;59(1):68-73. doi: 10.1016/j.advms.2013.08.001. Epub 2014 Mar 20.

PMID:
24797978
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk